Skip to content
Open access · OA via OpenAlex

Exosomes and tumor-mediated immune suppression

Theresa L. Whiteside

Journal of Clinical Investigation · 2016 · ▲ 576 citations

Abstract

Tumor-derived exosomes (TEX) are harbingers of tumor-induced immune suppression: they carry immunosuppressive molecules and factors known to interfere with immune cell functions. By delivering suppressive cargos consisting of proteins similar to those in parent tumor cells to immune cells, TEX directly or indirectly influence the development, maturation, and antitumor activities of immune cells. TEX also deliver genomic DNA, mRNA, and microRNAs to immune cells, thereby reprogramming functions of responder cells to promote tumor progression. TEX carrying tumor-associated antigens can interfere with antitumor immunotherapies. TEX also have the potential to serve as noninvasive biomarkers of tumor progression. In the tumor microenvironment, TEX may be involved in operating numerous signaling pathways responsible for the downregulation of antitumor immunity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1172/jci81136
Canonical
link ↗
Fetched
2026-06-08 MST

Cite this

APA
Whiteside, T.L. (2016). Exosomes and tumor-mediated immune suppression. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci81136
Vancouver
Whiteside TL. Exosomes and tumor-mediated immune suppression. Journal of Clinical Investigation. 2016. doi:10.1172/jci81136.
BibTeX
@article{theresa2016Exosom, title = {Exosomes and tumor-mediated immune suppression}, author = {Theresa L. Whiteside}, journal = {Journal of Clinical Investigation}, year = {2016}, doi = {10.1172/jci81136}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings